ActiveSight to Provide Crystallography Services to Inpharmatica
News Nov 23, 2005
ActiveSight has announced that it has signed an agreement to provide structural biology services to Inpharmatica Ltd.
The agreement focuses on co-crystallography by ActiveSight of certain Inpharmatica small molecules with a human drug target protein. The agreement includes upfront fees and payments for milestones.
"ActiveSight is delighted to augment Inpharmatica's unique drug discovery platform," stated Duncan McRee, Ph.D., President of ActiveSight.
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019